Empowering MSMEs with News & Insights

MCA21 system has Investor Complaint /serious Complaint e-forms available to stakeholders: Meghwal

Updated: Mar 25, 2017 06:45:32am
image

MCA21 system has Investor Complaint /serious Complaint e-forms available to stakeholders: Meghwal

New Delhi, Mar 25 (KNN) MCA21 system has Investor Complaint /serious Complaint e-forms which are available to Stakeholders for filing complaints online, Arjun Ram Meghwal, Minister of State for Corporate Affairs has said.

It has also a facility to process scanned complaints received through physical medium. 

Investor complaints received in the Ministry of Corporate Affairs and its field offices are forwarded to the concerned companies for remedial action.

In case the company fails to redress the grievance of the complainant and/ or is found to be in violation of the provisions of the Companies Act, suitable action under the provisions of the Companies Act 1956/2013 is initiated.

Further, in the meetings of the ‘Investor Grievance Resolution Forum’ held in offices of Registrars of Companies from time to time, complainants and representatives of companies meet and discuss to resolve investor grievances.

Investor awareness Programmes are being conducted through All India Radio, Doordarshan and short messaging service. There is no proposal to tap social media in this regard, Meghwal said this in a written reply to a question in Lok Sabha. 

Further, the Minister said the Ministry of Corporate Affairs organises Investors Awareness Programmes (IAPs) in association with the three Professional Institutes, namely Institute of Chartered Accountants of India (ICAI), Institute of Company Secretaries of India (ICSI), and Institute of Cost Accountants of India (ICoAI).

These programmes are conducted in Hindi, English and other vernacular languages depending upon the target audience. 

MCA organizes Investors Awareness Programmes (IAPs) in rural areas also through Common Service Centre (CSC) of Ministry of Electronics & Information Technology. 

COMMENTS

    Be first to give your comments.

LEAVE A REPLY

Required fields are marked *